Onderneming Intelligent Medicine Acquisition Corp.
Aandelen
IQMD
US45828D1063
Holdingvennootschappen
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Simon
CEO | Chief Executive Officer | 72 | 04-11-21 |
Geoffrey S. Ling
PRN | Corporate Officer/Principal | - | - |
Sue Siegel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | - | |
Jonathan Fleming
PRN | Corporate Officer/Principal | 66 | - |
Peter Knight
PRN | Corporate Officer/Principal | 73 | - |
Corporate Officer/Principal | 79 | - | |
Samir Khleif
PRN | Corporate Officer/Principal | 60 | - |
Llew Keltner
PRN | Corporate Officer/Principal | 74 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 04-11-21 | |
Jack Hidary
CHM | Chairman | 55 | 04-11-21 |
Gregory Simon
CEO | Chief Executive Officer | 72 | 04-11-21 |
Kavita Patel
BRD | Director/Board Member | 50 | 04-11-21 |
Director/Board Member | - | 04-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 175 000 | 5 175 000 ( 100,00 %) | 0 | 28,00 % |
Aandeel B | 1 | 20 700 000 | 2 070 000 ( 10,00 %) | 0 |
Bedrijfsgegevens
Intelligent Medicine Acquisition Corp.
9001 Burdette Road
20817, Bethesda
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+190,94% | 6,96 mld. | |
+2,14% | 982 mln. | |
+41,91% | 872 mln. | |
+26,98% | 830 mln. | |
+1,72% | 664 mln. | |
+5,92% | 642 mln. | |
-.--% | 600 mln. | |
+3,61% | 503 mln. | |
-.--% | 500 mln. |